Skip to content
2000
Volume 7, Issue 1
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Introduction

The purpose of this study was to investigate the demographic, clinical, and laboratory risk factors associated with mortality in Coronavirus disease 2019 (COVID-19) patients who were admitted to the intensive care unit (ICU) in Iran.

Materials & Methods

This retrospective study analyzed data from 867 COVID-19 patients admitted to the ICU of Shahid Beheshti Hospital in Hamadan (west of Iran) from September 2020 to March 2022. The association between demographic, clinical, and laboratory factors and mortality rates was assessed using univariable and multiple logistic regression analysis.

Results

During the study period, 512 (59.1%) patients were deceased from COVID-19. According to the adjusted logistic regression, the odds of death in patients with an age higher than 60 years were 1.12 (95% CI: 1.01- 1.24; =0.026). The OR estimate of death in patients with bradycardia and tachycardia was 2.32 (95% CI: 1.72- 3.12; < 0.001) and 2.40 (95% CI: 1.67- 3.42; < 0.001), respectively. Moreover, SPO lower than 88%, WBC over 11 ×1000µL, K over 5.2 mEq/L, and LDH above 942 U/L were significantly associated with increased odds of death ( < 0.05).

Conclusion

The study identified several demographic, clinical, and laboratory risk factors associated with mortality in COVID-19 patients admitted to the ICU in Iran. These findings can help healthcare providers identify patients at higher risk of poor outcomes and tailor interventions accordingly.

Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975323582240911070005
2024-09-20
2026-01-03
Loading full text...

Full text loading...

References

  1. CucinottaD. VanelliM. WHO declares COVID-19 a pandemic.Acta Biomed.202091115716032191675
    [Google Scholar]
  2. NalbandianA. SehgalK. GuptaA. Post-acute COVID-19 syndrome.Nat. Med.202127460161510.1038/s41591‑021‑01283‑z33753937
    [Google Scholar]
  3. KarlinskyA. KobakD. Tracking excess mortality across countries during the COVID-19 pandemic with the world mortality dataset.eLife202110e6933610.7554/eLife.6933634190045
    [Google Scholar]
  4. StokesE.K. ZambranoL.D. AndersonK.N. Coronavirus disease 2019 case surveillance—United States, January 22–May 30, 2020.MMWR Morb. Mortal. Wkly. Rep.2020692475976510.15585/mmwr.mm6924e232555134
    [Google Scholar]
  5. NilsenP. SeingI. EricssonC. Implementing social distancing policy measures in the battle against the coronavirus: Protocol of a comparative study of Denmark and Sweden.Implement. Sci. Commun.2020117710.1186/s43058‑020‑00065‑x32968739
    [Google Scholar]
  6. SanyaoluA. OkorieC. MarinkovicA. Comorbidity and its impact on patients with COVID-19.SN Compr. Clin. Med.2020281069107610.1007/s42399‑020‑00363‑432838147
    [Google Scholar]
  7. KrynytskaI. MarushchakM. BirchenkoI. DovgalyukA. TokarskyyO. COVID-19-associated acute respiratory distress syndrome versus classical acute respiratory distress syndrome (a narrative review).Iran. J. Microbiol.202113673774710.18502/ijm.v13i6.807235222850
    [Google Scholar]
  8. WuC. ChenX. CaiY. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 Pneumonia in Wuhan, China.JAMA Intern. Med.2020180793494310.1001/jamainternmed.2020.099432167524
    [Google Scholar]
  9. Salim BahramiS.A.R. KhamseM. SanaeiZ. KarkhaneiB. Relationship of oxygen saturation percentage (SaO2) and arterial oxygen pressure (PaO2) with the outcome of COVID-19 patients hospitalized in intensive care units.AJCM2023294204210
    [Google Scholar]
  10. DriesD.J. Coronavirus disease 2019: From intensive care unit to the long haul—part 2.Air Med. J.202140529830210.1016/j.amj.2021.03.01734535232
    [Google Scholar]
  11. DarM. SwamyL. GavinD. TheodoreA. Mechanical-ventilation supply and options for the COVID-19 pandemic. Leveraging all available resources for a limited resource in a crisis.Ann. Am. Thorac. Soc.202118340841610.1513/AnnalsATS.202004‑317CME33202144
    [Google Scholar]
  12. TalebiS.S. HosseinzadehA. ZareF. Risk factors associated with mortality in COVID-19 patient’s: Survival analysis.Iran. J. Public Health202251365265810.18502/ijph.v51i3.894235865069
    [Google Scholar]
  13. Al OweidatK. Al-AmerR. SalehM.Y. Mortality, intensive care unit admission, and intubation among hospitalized patients with COVID-19: A one-year retrospective study in Jordan.J. Clin. Med.2023127265110.3390/jcm1207265137048734
    [Google Scholar]
  14. GrasselliG. ZangrilloA. ZanellaA. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy.JAMA2020323161574158110.1001/jama.2020.539432250385
    [Google Scholar]
  15. ZaliA. GholamzadehS. MohammadiG. Baseline characteristics and associated factors of mortality in COVID-19 patients; an analysis of 16000 cases in Tehran, Iran.Arch. Acad. Emerg. Med.202081e7033134966
    [Google Scholar]
  16. StataCorp LLCataCorp L. Stata Statistical SoftwareRelease 12.StataCorp2011
    [Google Scholar]
  17. DuR.H. LiangL.R. YangC.Q. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: A prospective cohort study.Eur. Respir. J.2020555200052410.1183/13993003.00524‑202032269088
    [Google Scholar]
  18. MikamiT. MiyashitaH. YamadaT. Risk factors for mortality in patients with COVID-19 in New York City.J. Gen. Intern. Med.2021361172610.1007/s11606‑020‑05983‑z32607928
    [Google Scholar]
  19. LiC. YeJ. ChenQ. Elevated lactate dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19.Aging20201215156701568110.18632/aging.10377032805722
    [Google Scholar]
  20. MejíaF. MedinaC. CornejoE. Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru.PLoS One20201512e024417110.1371/journal.pone.024417133370364
    [Google Scholar]
  21. LiuY. DuX. ChenJ. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.J. Infect.2020811e6e1210.1016/j.jinf.2020.04.00232283162
    [Google Scholar]
/content/journals/covid/10.2174/0126667975323582240911070005
Loading
/content/journals/covid/10.2174/0126667975323582240911070005
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test